Respiratory Tract Infections (RTI)
12
4
5
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
25%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (12)
Impact of AHCC® Supplementation for Prevention of Respiratory Tract Infections Among Children Age 2-4 Years Old
Effect of Pleuran on the Clinical Course of Patients With Chronic Rhinosinusitis
Clinical Assessment of Respiratory Events for Kids: Integrating Diagnostics and Stewardship
The Influence of Explainability and Integrability of AI-CDSS on Usage Behavior Among Primary Care Physicians
Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race
Comparing and Predicting the Risk of Respiratory Tract Infection (RTI) Among Post-menopausal Women on or Without Hormone Replacement Therapy (HRT): an Observational Cohort Study
Respiratory Infections in Young Children
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
Optimal Implementation of Antimicrobial Stewardship in General Practice
To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
OM 85 to Prevent Respiratory Infections in Older At Risk Patients
Iron and Prebiotics Fortification in Kenyan Infants